MSI1

LY2874455 : Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455

Peptide 17:Design of Peptides that Fold and Self-Assemble on Graphite

Heptadecanoic acid : Safety evaluation of odd-chain fatty acid algal oil

Tebipenem Pivoxil : Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media

Tasquinimod: Immunothérapie dans les cancers de la prostate

Semaglutide : Semaglutide: First Global Approval

Idelalisib : Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia

MG149 : Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer

Gandotinib: Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice

Muvalaplin: The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE